- 1
Thomason M J, Strachan D P.
Which spirometric indices best predict subsequent death from chronic obstructive pulmonary
disease?.
Thorax.
2000;
55
785-788
- 2
Celli B R, Cote C G, Marin J M. et al .
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in
chronic obstructive pulmonary disease.
N Engl J Med.
2004;
350
1005-1012
- 3
Martinez F J, Foster G, Curtis J L. et al .
Predictors of mortality in patients with emphysema and severe airflow obstruction.
Am J Respir Crit Care Med.
2006;
173
1326-1334
- 4
Franciosi L G, Page C P, Celli B R. et al .
Markers of disease severity in chronic obstructive pulmonary disease.
Pulm Pharmacol Ther.
2006;
19
189-199
- 5
Donaldson G C, Seemungal T A, Bhowmik A. et al .
Relationship between exacerbation frequency and lung function decline in chronic obstructive
pulmonary disease.
Thorax.
2002;
57
847-852
- 6
Connors Jr A F, Dawson N V, Thomas C. et al .
Outcomes following acute exacerbation of severe chronic obstructive lung disease.
The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes
and Risks of Treatments).
Am J Respir Crit Care Med.
1996;
154
959-967
- 7
Soler-Cataluna J J, Martinez-Garcia M A, Roman S P. et al .
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary
disease.
Thorax.
2005;
60
925-931
- 8
Spencer S, Jones P W.
Time course of recovery of health status following an infective exacerbation of chronic
bronchitis.
Thorax.
2003;
58
589-593
- 9
Fulco P P, Lone A A, Pugh C B.
Intravenous versus oral corticosteroids for treatment of acute asthma exacerbations.
Ann Pharmacother.
2002;
36
565-570
- 10
Schuh S, Reisman J, Alshehri M. et al .
A comparison of inhaled fluticasone and oral prednisone for children with severe acute
asthma.
N Engl J Med.
2000;
343
689-694
- 11
Niewoehner D E, Erbland M L, Deupree R H. et al .
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary
disease. Department of Veterans Affairs Cooperative Study Group.
N Engl J Med.
1999;
340
1941-1947
- 12
Nair S, Thomas E, Pearson S B. et al .
A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol
in acute exacerbations of COPD.
Chest.
2005;
128
48-54
- 13
Soto F J, Varkey B.
Evidence-based approach to acute exacerbations of COPD.
Curr Opin Pulm Med.
2003;
9
117-124
- 14 Global Initiative for Chronic Obstructive Lung Disease .Global strategy for the
diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated
2004. NHLBI/WHO Workshop Report, Executive Summary. National Institutes of Health.
National Heart, Lung, and Blood Institute. World Health Organisation 2006
- 15
Miller D D, Amin M M, Palmer L B. et al .
Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation.
Am J Respir Crit Care Med.
2003;
168
1205-1209
- 16
Rodrigo G, Pollack C, Rodrigo C. et al .
Heliox for treatment of exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev.
2002;
DOI: 10.1002/14651858.CD003571
- 17
Masood A R, Thomas S H.
Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects.
Br J Clin Pharmacol.
1996;
41
250-252
- 18
Foral P A, Malesker M A, Huerta G. et al .
Nebulized opioids use in COPD.
Chest.
2004;
125
691-694
- 19
Abernethy A P, Currow D C, Frith P. et al .
Randomised, double blind, placebo controlled crossover trial of sustained release
morphine for the management of refractory dyspnoea.
BMJ.
2003;
327
523-528
- 20
Rutten F H, Cramer M J, Lammers J W. et al .
Heart failure and chronic obstructive pulmonary disease: An ignored combination?.
Eur J Heart Fail.
2006;
8
706-11
- 21
Ram F S, Picot J, Lightowler J. et al .
Non-invasive positive pressure ventilation for treatment of respiratory failure due
to exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev.
2004;
DOI: 10.1002/14651858. CD004104.pub3
- 22
Davidson A C.
The pulmonary physician in critical care. 11: critical care management of respiratory
failure resulting from COPD.
Thorax.
2002;
57
1079-1084
- 23
Burns K E, Adhikari N K, Meade M O.
Noninvasive positive pressure ventilation as a weaning strategy for intubated adults
with respiratory failure.
Cochrane Database Syst Rev.
2003;
DOI: 10.1002/14651858.CD004127.
DOI: 10.1002/14651858. CD004127.
- 24
Vandenbergh E, Woestijne K P van de, Gyselen A.
Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation
to respiratory function and prognosis.
Am Rev Respir Dis.
1967;
95
556-566
- 25
Landbo C, Prescott E, Lange P. et al .
Prognostic value of nutritional status in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
1999;
160
1856-1861
- 26
Marquis K, Debigare R, Lacasse Y. et al .
Midthigh muscle cross-sectional area is a better predictor of mortality than body
mass index in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2002;
166
809-813
- 27
Bernard S, LeBlanc P, Whittom F. et al .
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
1998;
158
629-634
- 28
Pitta F, Troosters T, Spruit M A. et al .
Characteristics of physical activities in daily life in chronic obstructive pulmonary
disease.
Am J Respir Crit Care Med.
2005;
171
972-977
- 29
Schols A M, Slangen J, Volovics L. et al .
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary
disease.
Am J Respir Crit Care Med.
1998;
157
1791-1797
- 30
Schols A M, Wouters E F.
Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease.
Clin Chest Med.
2000;
21
753-762
- 31
Creutzberg E C, Schols A M, Buurman W A. et al .
Characterization of nonresponse to high caloric oral nutritional therapy in depleted
patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2000;
161
745-752
- 32
Sala E, Roca J, Marrades R M. et al .
Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive
pulmonary disease.
Am J Respir Crit Care Med.
1999;
159
1726-1734
- 33
Lacasse Y, Wong E, Guyatt G H. et al .
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet.
1996;
348
1115-1119
- 34
Schols A M, Soeters P B, Mostert R. et al .
Physiologic effects of nutritional support and anabolic steroids in patients with
chronic obstructive pulmonary disease. A placebo-controlled randomized trial.
Am J Respir Crit Care Med.
1995;
152
1268-1274
- 35
Anker S D, John M, Pedersen P U. et al .
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology.
Clin Nutr.
2006;
25
311-318
- 36
Morlion B J, Stehle P, Wachtler P. et al .
Total parenteral nutrition with glutamine dipeptide after major abdominal surgery:
a randomized, double-blind, controlled study.
Ann Surg.
1998;
227
302-308
- 37
Berghe G van den, Wouters P, Weekers F. et al .
Intensive insulin therapy in the critically ill patients.
N Engl J Med.
2001;
345
1359-1367
- 38
Weiner P, Magadle R, Beckerman M. et al .
Maintenance of inspiratory muscle training in COPD patients: one year follow-up.
Eur Respir J.
2004;
23
61-65
- 39
Nici L, Donner C, Wouters E. et al .
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.
Am J Respir Crit Care Med.
2006;
173
1390-1413
- 40
Neder J A, Sword D, Ward S A. et al .
Home based neuromuscular electrical stimulation as a new rehabilitative strategy for
severely disabled patients with chronic obstructive pulmonary disease (COPD).
Thorax.
2002;
57
333-337
- 41
Benditt J O.
Surgical options for patients with COPD: sorting out the choices.
Respir Care.
2006;
51
173-182
- 42
Tiong L U, Davies R, Gibson P G. et al .
Lung volume reduction surgery for diffuse emphysema.
Cochrane Database Syst Rev.
2006;
DOI: 10.1002/14651858.CD001001pub2
DOI: 10.1002/14651858. CD001001pub2
- 43
Naunheim K S, Wood D E, Mohsenifar Z. et al .
Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical
Therapy for Severe Emphysema by the National Emphysema Treatment Trial Research Group.
Ann Thorac Surg.
2006;
82
431-443
- 44
Fabbri L M, Luppi F, Beghe B. et al .
Update in chronic obstructive pulmonary disease 2005.
Am J Respir Crit Care Med.
2006;
173
1056-1065
- 45
Ingenito E P, Reilly J J, Mentzer S J. et al .
Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy
for emphysema.
Am J Respir Crit Care Med.
2001;
164
295-301
- 46
Orens J B, Estenne M, Arcasoy S. et al .
International guidelines for the selection of lung transplant candidates: 2006 update
- a consensus report from the Pulmonary Scientific Council of the International Society
for Heart and Lung Transplantation.
J Heart Lung Transplant.
2006;
25
745-755
- 47
De Meester J, Smits J M, Persijn G G. et al .
Listing for lung transplantation: life expectancy and transplant effect, stratified
by type of end-stage lung disease, the Eurotransplant experience.
J Heart Lung Transplant.
2001;
20
518-524
- 48
Rosenwax L K, McNamara B, Blackmore A M. et al .
Estimating the size of a potential palliative care population.
Palliat Med.
2005;
19
556-562
- 49
Gore J M, Brophy C J, Greenstone M A.
How well do we care for patients with end stage chronic obstructive pulmonary disease
(COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.
Thorax.
2000;
55
1000-1006
- 50
Claessens M T, Lynn J, Zhong Z. et al .
Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT.
Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
J Am Geriatr Soc.
2000;
48
S146-S153
- 51
Worth H, Buhl R, Cegla U. et al .
Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft fur Pneumologie
zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und
Lungenemphysem (COPD).
Pneumologie.
2002;
56
704-738
- 52 Lelgemann M, Thalau F, Ollenschläger G. et al .Nationale Versorgungs-Leitlinie
COPD. 3.0. 2006
- 53
Jennings A L, Davies A N, Higgins J P. et al .
A systematic review of the use of opioids in the management of dyspnoea.
Thorax.
2002;
57
939-944
- 54
Juan G, Ramon M, Valia J C. et al .
Palliative treatment of dyspnea with epidural methadone in advanced emphysema.
Chest.
2005;
128
3322-3328
- 55
Kunik M E, Roundy K, Veazey C. et al .
Surprisingly high prevalence of anxiety and depression in chronic breathing disorders.
Chest.
2005;
127
1205-1211
- 56
Hirst A, Sloan R.
Benzodiazepines and related drugs for insomnia in palliative care.
Cochrane Database Syst Rev.
2001;
Issue 4.
Art-No.: CD003346. DOI: 10.1002/14651858.CD003346.-Art-No.:CD003346. DOI: 10.1002/14651858.CD003346.
- 57
Knauft E, Nielsen E L, Engelberg R A. et al .
Barriers and facilitators to end-of-life care communication for patients with COPD.
Chest.
2005;
127
2188-2196
Prof. Dr. med. Gratiana Steinkamp
Klinische Forschung, Medizinisch-wissenschaftliches Publizieren
Schellingstr. 5a
30625 Hannover
Email: steinkamp@med-wiss.com
